|
2024
|
P/S
|
Diagnostic preparations for industrial and scientific use;
chemical reagents for industrial use;... |
|
|
P/S
|
Diagnostic preparations for industrial and scientific use; chemical reagents for industrial use; ... |
|
|
Invention
|
Non-invasive diagnostic of non-alcoholic steatohepatitis.
The invention relates to a novel metho... |
|
|
Invention
|
Kits and methods for multiplex immuno-pcr. The present invention relates to a kit for performing ... |
|
|
Invention
|
Method of diagnostic of liver fibrosis. The invention relates to a method for the identification ... |
|
|
P/S
|
Software; downloadable software applications; scientific
apparatus and instruments particularly ... |
|
|
P/S
|
Downloadable and recorded software for use in the management of cancer, metabolic diseases and li... |
|
|
Invention
|
Solid dosage forms of elafibranor. The present invention relates to formulations of elafibranor o... |
|
2023
|
Invention
|
Use of transmembrane ph gradient liposomes for treating hyperammonemic crisis associated with inb... |
|
|
Invention
|
Methods of treatment of cholestatic diseases.
The present invention relates to the use of compou... |
|
|
Invention
|
Ppar-alpha/gamma agonist for use in the treatment of liver failure. The invention relates to comp... |
|
|
P/S
|
Downloadable software for use in diagnosis of metabolic diseases and liver diseases, and in resea... |
|
|
P/S
|
Pharmaceutical, veterinary and sanitary products for medical
use; chemical preparations for medi... |
|
|
P/S
|
Pharmaceutical and veterinary products, namely, pharmaceutical and veterinary preparations for pr... |
|
|
P/S
|
Pharmaceutical and veterinary products; chemical
preparations for medical or pharmaceutical use. |
|
|
Invention
|
Nitazoxanide for the treatment of hepatic impairment. The present invention relates to a compound... |
|
|
Invention
|
Methods for diagnosing advanced liver fibrosis or liver cirrhosis. Provided herein is a method of... |
|
|
P/S
|
Pharmaceutical and veterinary preparations; Chemical preparations for medical or pharmaceutical p... |
|
|
Invention
|
Methods of treatment of cholestatic diseases. The present invention relates to the use of compoun... |
|
|
P/S
|
Scientific research for medical purposes; pharmaceutical research and development services; scien... |
|
|
P/S
|
Scientific research for medical purposes; pharmaceutical
research and development services; cond... |
|
|
Invention
|
Improved diagnosis of nonalcoholic steatohepatitis. The present invention provides improved metho... |
|
2022
|
Invention
|
Methods of treatment for cholestatic and fibrotic diseases.
The present invention relates to a s... |
|
|
Invention
|
Methods for diagnosing and evaluating non-alcoholic steatohepatitis.
The invention relates to a ... |
|
|
Invention
|
Method for nash risk assessment in patients having a metabolic disorder.
The present invention r... |
|
|
Invention
|
Method for nash risk assessment in patients having a metabolic disorder. The present invention re... |
|
|
Invention
|
Nitazoxanide in the treatment of sepsis.
The present invention relates to a compound selected fr... |
|
|
Invention
|
Elafibranor derivatives agonists of ppar for use in the treatment of sepsis.
The invention relat... |
|
|
Invention
|
Ppar-agonists for use in the treatment of liver failure.
The invention relates to compounds for ... |
|
|
Invention
|
Ppar-agonists for use in the treatment of liver failure. The invention relates to compounds for u... |
|
|
Invention
|
Elafibranor derivatives agonists of ppar for use in the treatment of sepsis. The invention relate... |
|
|
Invention
|
Nitazoxanide in the treatment of sepsis. The present invention relates to a compound selected fro... |
|
|
Invention
|
Elafibranor and 2-[2,6-dimethyl-4-[3-[4-(methylthio)phenyl]-3-oxo-propyl] phenoxy]-2-methylpropan... |
|
|
Invention
|
Quantitative detection of micro-rnas. The present invention is directed to novel compositions and... |
|
2021
|
P/S
|
Reagents for chemical analyses; reagents for scientific use;
reagents for scientific or medical ... |
|
|
P/S
|
Reagents for chemical analyses for scientific use; reagents for scientific use; reagents for scie... |
|
|
P/S
|
Business services relating to online service provision, namely, collection of data and informatio... |
|
|
P/S
|
Services relating to online service provision, namely
collection of data and information in the ... |
|
|
Invention
|
Methods of treatment of liver failure.
The invention relates to the treatment or prevention of l... |
|
|
Invention
|
Methods of diagnostic of liver fibrosis.
The invention relates to a method for the identificatio... |
|
|
P/S
|
Business services relating to online service provision, namely collection of data and information... |
|
|
P/S
|
Reagents for chemical analyses; reagents for scientific
use; reagents for scientific or medical ... |
|
|
Invention
|
Compositions and methods for the treatment of primary biliary cholangitis.
The invention relates... |
|
|
Invention
|
Method for nash risk assessment.
The present invention relates to a new assay to diagnose nonalc... |
|
|
P/S
|
Pharmaceutical products; chemical preparations for medical
or pharmaceutical use; organic prepar... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of liver diseases, cholesterol disea... |
|
|
Invention
|
In vitro model of liver steatohepatitis.
The present invention relates to methods for preparing ... |
|
|
P/S
|
Pharmaceuticals; Chemical preparations for medical or pharmaceutical purposes; Biological prepara... |
|
|
Invention
|
Elafibranor for the treatment of primary sclerosing cholangitis.
The present invention relates t... |
|
|
Invention
|
Quantitative detection of micro-rnas.
The present invention is directed to novel compositions an... |
|
|
Invention
|
Polymorphs of elafibranor.
The present invention relates to novel crystalline forms of elafibranor. |
|
|
Invention
|
Treatment of primary biliary cholangitis with elafibranor.
The invention relates to a pharmaceut... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of liver diseases, cholestatic disea... |
|
2020
|
Invention
|
Phosphate derivatives of rorgamma modulators and uses thereof.
The present invention relates to ... |
|
|
Invention
|
Combination therapy having antioxydant properties.
The present invention relates to novel uses o... |
|
|
Invention
|
Method for treatment of at risk patients.
The invention provides an anti-fibrotic or anti-nonalc... |
|
|
Invention
|
Compositions and methods for the stabilization of micro-rna.
The present invention relates to th... |
|
|
Invention
|
Nitazoxanide and thiazolides for use in the treatment of diseases associated with oxidative stres... |
|
|
P/S
|
Diagnostic preparations for scientific use; Chemical reagents for industrial use, other than for ... |
|
|
P/S
|
Diagnostic preparations for industrial and scientific purposes; Chemical reagents for industrial ... |
|
|
P/S
|
Scientific apparatus and instruments in the field of clinical research and diagnostics for use in... |
|
2019
|
P/S
|
Pharmaceutical and veterinary preparations for the prevention and treatment of liver diseases, me... |
|
|
P/S
|
Pharmaceutical and veterinary products; chemical
preparations for medical or pharmaceutical use;... |
|
|
P/S
|
Pharmaceutical research (research for the discovery of new drugs); Scientific research, in partic... |
|
|
P/S
|
Software; downloadable software applications; Scientific,
optical, weighing, measuring, signalin... |
|
|
P/S
|
Computer software; Downloadable software applications; Scientific, optical, weighing, measuring, ... |
|
|
P/S
|
Reagent for chemical analyses; Reagents for scientific purposes; Reagents for medical research; D... |
|
|
P/S
|
Reagents for chemical analyses; reagents for scientific
use; reagents for medical research; diag... |
|
|
P/S
|
Reagents for chemical analyses other than for medical or veterinary purposes; reagents for scient... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of metabolic disorders and liver dis... |
|
|
P/S
|
Pharmaceutical preparations; diagnostic preparations for
medical use; diagnostic testing materia... |
|
|
P/S
|
Pharmaceutical preparations; diagnostic preparations;
material (reagents or substances) for diag... |
|
|
P/S
|
Pharmaceutical preparations; Diagnostic preparations; Diagnostic testing materials for medical us... |
